Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharm Exam 2 > Kapatos: Sedative-Hypnotic Drugs > Flashcards

Kapatos: Sedative-Hypnotic Drugs Flashcards

1
Q

Definitions
Sedatives:
Hypnotics:

A

Sedatives: produce calming or drowsiness

Hypnotics: facilitate onset and maintenance of sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification (Sedative or Hypnotic):

A

Assignment indicates therapeutic use for sedation (relief of anxiety) or to encourage sleep (hypnosis)

Classification based on clinical use rather than structure due to chemical heterogeneity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classification (Sedative or Hypnotic):

Benzodiazepines vs. Barbituates

A

Can also be classified based on duration of action
o Benzodiazepines can be short, intermediate or long acting
o Barbituates can be ultra-short, short or long acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Effects:

A

Effects: dose-dependent CNS depressant effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Subgroups (2)

A

Subgroups:

  • Benzodiazepines: most important subgroup
  • Barbituates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Miscellaneous Agents: (7)

A 
o	Meprobamate (carbamate)
o	Chloral hydrate (alcohol)
o	Buspirone
o	Zolpidem
o	Zaleplon
o	Eszopiclone
o	Ramelteon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Non-Prescription Hypnotics: (3)

A

Antihistamines

Serotonin Precursor

Product of Serotonin Biosynthetic Pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antihistamines: (2)

A

Antihistamines:
o Diphenyhydramine
o Doxylamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Serotonin Precursor:

A

Serotonin Precursor: L-tryptophan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Product of Serotonin Biosynthetic Pathway:

A

Product of Serotonin Biosynthetic Pathway: melatonin (synthesized and secreted by pineal gland in a circadian rhythm controlled by SS nervous system)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Absorption and Distribution

Highly Lipid Soluble:

A

Cross BBB after absorption from the GI tract

Lipophilic nature causes some benzos to be unreliable after IM injection
- For example, chlordiazepam and diazepam

Thiopental (barbiturate) has the highest lipid solubility and enters the CNS rapidly (used for induction of anesthesia)
- CNS effects rapidly terminated by redistribution of the drug to other tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Absorption and Distribution

Important Point:

A

Due to high lipid solubility, all sedative-hypnotics cross the placenta (depress normal neonatal vital functions)

Also detected in breast milk (depressive effects in nursing infants)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Benzodiazepine Metabolism

Phase I Reactions:

A

Phase I Reactions: many (but not all) undergo hepatic microsomal oxidation by P450 enzymes (CYP3A4/2C19)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Benzodiazepine Metabolism

Phase II Reactions:

A

Phase II Reactions: all are eventually conjugated to form glucuronides that are excreted in the urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CYP3A4 Interactions: (5)

A

Inhibition: increases blood levels of benzodiazepines
o Erythromycin and clarithromycin (macrolides)
o Itraconazole and ketoconazole (antifungals)
o Nefazodone
o Grapefruit juice
o Cimetidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Active Metabolites:

What agents accumulate after continuous dosing? (2)

A

Active Metabolites: many metabolites of benzodiazepines are biologically active (long half-lives)

  • Accumulate after continuous dosing: occurs with some drugs, leading to excessive sedation
  • Diazepam and flurazepam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Continuous Dosing

Accumulation may occur in :
Less of an issue with:
What do not undergo hepatic microsomal activation and are conjugated directly?

A

Accumulation may occur in drugs with long half-lives (see above)

Less of an issue with benzodiazepines with shorter half lives (no active metabolites)

Oxazepam and lorazepam (do not undergo hepatic microsomal activation and are conjugated directly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Zolpidem/Zaleplon/Eszopiclone

A

Short Duration of Action: due to rapid metabolism by liver enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Overall Duration of Action

Can be only a few hours: (5)

A 
Eszopiclone
Zaleplon
Zolpidem
Triazolam
Chloral hydrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Overall Duration of Action

Can be as long as >30 hours: (4)

A

Chlordiazepoxide
Clorazepate
Diazepam
Phenobarbital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mechanism of Action

General:

A

No single MOA has been identified, and different subgroups may have different actions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Benzodiazepines

Receptors:

A

Located in many areas of the brain (thalamus, limbic structures, cerebral cortex)

Form part of the GABAA receptor-chloride ion channel macromolecule complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Benzodiazepines

Receptor Binding:

A

Facilitates the inhibitory actions of GABA by increasing the chloride ion conductance and hyperpolarizing the membrane (therefore, you need to have GABA present for these to work)

Increase the FREQUENCY of GABA-mediated chloride channel opening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Benzodiazepines

Receptor Antagonist:

A

Receptor Antagonist: Flumazenil (reverses CNS effects of benzos)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Barbituates

Receptor:

A

Receptor: do not compete for BZ or GABA binding; appear to interact with other sites on GABAA receptor chloride ion channel

26
Q

Barbituates
Receptor Binding:

Depresses:
Increases:

A

Depresses neuronal activity by PROLONGING the effects of the inhibitory effects of GABA and glycine (therefore, also need GABA to be present for these drugs to work)

Increase the DURATION of GABA-mediated chloride channel opening

27
Q

Buspirone:
MOA:
Hypnotic, euphoric, muscle relaxant or anticonvulsant effects?
Cross-tolerance with benzos:

A

Buspirone: partial agonist at 5HT1A receptors AND agonist/antagonist at DA D2 receptor

Precise mechanism of anxiolytic effects unknown

No hypnotic, euphoric, muscle relaxant or anticonvulsant effects

No cross-tolerance with benzos

28
Q

Buspirone

Potentiate effects of other sedative hypnotics?
Benzo withdrawal:
If you want to switch to buspirone:
Drug free interval:

A

Does not potentiate effects of other sedative hypnotics (including alcohol)

  • Therefore, substitution of buspirone will NOT lessen/prevent benzo withdrawal
  • If you want to switch to buspirone, need to first withdraw from benzo gradually
  • Drug free interval between the 2 permits the physician to distinguish between withdrawal effects of benzos and failure of buspirone once employed
29
Q

Eszopiclone/Zolpidem/Zaleplon

A

Eszopiclone/Zolpidem/Zaleplon: hypnotics that modulate GABAA receptor via interaction with BZ binding site (but these are NOT benzos)

Because of MOA, also antagonized by flumazenil

30
Q

Ramelteon

A

Ramelteon: melatonin receptor agonist

Approved for sleep-onset insomonia (not for sleep maintenance)

No abuse potential and is not a controlled substance

Increased serum prolactin and decreased serum testosterone are possible side effects

31
Q

Pharmacodynamics
General:
Depressant effects often:
Steepness of dose-response curve correlated with:

A

CNS effects of these drugs are highly dose-dependent (effects can range from sedation to coma, depending on the dose)

Depressant effects often ADDITIVE when two or more drugs given together

Steepness of dose-response curve correlated with safety

  • Flatter curves (ie. benzos) safer
  • Steeper curves (ie. barbiturates) less safe
32
Q

Sedation
What occurs with ALL drugs in this class?
Usually accompanied by:

A

Both sedation and relief from anxiety occurs with ALL drugs in this class

Usually accompanied by:

  • Impaired psychomotor functions
  • Behavioral disinhibition
33
Q

Hypnosis
High doses of benzodiazepines can lead to:
Withdrawal from chronic drug use can lead to:

A

Promote sleep onset and increase duration of sleep

  • High doses of benzodiazepines can lead to decreased REM sleep
  • Withdrawal from chronic drug use can lead to rebound increase in REM sleep
34
Q

Anesthesia
Loss of consciousness:
Anterograde amnesia more common with:
Anesthesia can be produced by:

A

Loss of consciousness may occur at high doses (with amnesia and suppression of reflexes)

  • Anterograde amnesia more common with benzos
  • Anesthesia can be produced by most barbiturates and certain benzos (midazolam)
35
Q

Anticonvulsant Actions

Seizures:
Anticonvulsant actions:
Status epilepticus:

A

Suppression of seizures occurs at high doses of most barbiturates and some benzos
- However, marked sedation is a problematic side effect

Selective anticonvulsant actions (ie. do not cause severe sedation) occurs only with a few drugs

  • Phenobarbital
  • Clonazepam

Treatment of status epilepticus
- High doses of IV diazepam, lorazepam or Phenobarbital (induce heavy sedation)

36
Q

Muscle Relaxation

Skeletal muscle relaxation:
What is effective at SEDATIVE DOSES?
Meprobamate:

A

Skeletal muscle relaxation occurs at LOW DOSES

Use in specific spasticity states (ie. cerebral palsy)
- Diazepam is effective at SEDATIVE DOSES

Meprobamate has some SELECTIVITY as a muscle relaxant

37
Q

Medullary Depression

High doses effects: (3)

A

High doses can cause depression of medullary neurons

  • Respiratory arrest
  • Hypotension
  • CV collapse

These effects are the cause of death in OD

38
Q

Tolerance:

A

Tolerance: decrease in responsiveness to the drug over time

Occurs when sedative-hypnotics used CHRONICALLY or in HIGH DOSES

Cross tolerance may occur across subgroups

39
Q

Tolerance to Benzodiazepines

Associated with:
Rapid rebound in these receptors occurs when?

A

Associated with downregulation of BZ receptors (GABAA receptors)

Rapid rebound in these receptors occurs upon termination of benzo treatment

40
Q

Psychologic Dependence

A

Occurs frequently with most sedative-hypnotics

Manifested by compulsive use to reduce anxiety

41
Q

Physiological Dependence:

A

Constitutes an altered state that leads to an abstinence syndrome (withdrawal state) when drug is discontinued

42
Q

Physiological Dependence

Due to downregulation of BZ receptors, benzodiazepine withdrawal produces:

Occurs more commonly with:
Does not occur with:
Less of an issue with _____ than benzos

A

Due to downregulation of BZ receptors, benzodiazepine withdrawal produces neuronal hyperexctiability (anxiety, tremors, hyperrflexia, seizures)

Occurs more commonly with shorter-acting drugs (ie. pentobarbital or triazolam)

Does not occur with longer acting drugs (ie. diazepam) because they self-taper

Less of an issue with zopidem/zalepon/eszopiclone than benzos

43
Q

Clinical Use
Anxiety States

Preferred Agents:

A

Preferred Agents: benzodiazepines with intermediate or long durations of action (ie. diazepam)

44
Q

Clinical Use

Panic and Phobic Disorders: (2)

A

Alprazolam (Xanax)

Clonazepam

45
Q

Buspirone
General Rule:
Use:

A

Buspirone: anxiolytic effects WITHOUT sedation of cognitive impairment; however, effects take a week or more to develop

General Rule:

  • Put on a benzo first to immediately treat anxiety
  • Then taper and use buspirone

Use: generalized anxiety disorder (GAD) in patients with a past history of substance abuse

46
Q

Clinical Use
Sleep Disorders

Benzodiazepines: (2)

A

Benzodiazepines: widely used for primary insomnia and other sleep disorders

  • Flurazepam
  • Triazolam
47
Q

Clinical Use
Sleep Disorders

Zolpidem/Eszopiclone/Zaleplon:

A

Cause less daytime impairment than most benzodiazepines

Minimal effects on sleep patterns (no rebound increase in REM sleep)

48
Q

Clinical Use
Anesthesia

Induction:
Components of Protocol:

A

Induction: thiopental

Components of Protocol: diazepam and midazolam

49
Q

Clinical Use

Seizure Disorders: (2)

A

Clonazepam

Phenobarbital

50
Q

Clinical Use

Spasticity: (1)

A

Diazepam

51
Q

Clinical Use

Management of Withdrawal:
Longer acting agents: (2)

A

Management of Withdrawal: in people physiologically dependent on EtOH or other sedative-hypnotics

Longer acting agents: chlordiazpoxide, diazepam

52
Q

Toxicity
Psychomotor Dysfunction

Includes:

A

Includes: cognitive impairment, decreased psychomotor skills, unwanted daytime sedation

53
Q

Toxicity
Psychomotor Dysfunction

More common with: (2)
Short acting hypnotics:

A

More common with benzodiazepines that have long-lived active metabolites
- Diazepam and flurazepam

Short acting hypnotics (esp. triazolam) may cause daytime anxiety and amnesia

Anterograde amnesia may also occur with high doses of benzos
- Basis for use in cases of “date rape”

54
Q

Toxicity
Psychomotor Dysfunction
Caution:

A

Caution: dosage in elderly patients should be decreased by at least 50% to avoid daytime sedation

  • Increases risks of falls and fractures
  • Sedation in elderly due to CHANGE IN BRAIN FUNCTION, not change in liver metabolism
55
Q

Toxicity
Additive CNS Depression

DDIs: (5)

A
  • Alcoholic beverages
  • Antihistamines
  • Antipsychotics
  • Opioid analgesics
  • TCAs
56
Q

Toxicity
Additive CNS Depression

Inhibition of Benzodiazepine Metabolism (CYP3A4 interactions):
Buspirone:

A

Inhibition of Benzodiazepine Metabolism (CYP3A4 interactions): see previous notes

Buspirone: additive CNS depression uncommon

57
Q

Toxicity
Overdose

Respiratory and CV Depression:

A

Respiratory and CV Depression:

  • More likely with alcohols, barbiturates and carbamates than with benzos
  • More pronounced in people with respiratory depression, sleep apnea or CV disease
58
Q

Toxicity
Overdose

Management:
______ can reverse CNS effects of benzos, zolpidem, zaleplon and eszopiclone:

A

Requires maintenance of patent airway and ventilatory support

Flumazenil can reverse CNS effects of benzos, zolpidem, zaleplon and eszopiclone ONLY

  • Needs to be administered repeatedly due to short half-life
  • Also important to take care with use in patients that have a history of seizures
59
Q

Induction of the formation of liver microsomal enzymes that increase drug metabolism: (2)

A

Barbituates and carbamates only

60
Q

Precipitation of acute intermittent porphyria:

A

Barbiturates (in susceptible patients)

61
Q

Displacement of coumarins from plasma protein binding sites:

A

Chloral hydrate (increase anticoagulant effects)

Pharm Exam 2 (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions